Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,363 | -3,536 | 3,586 | 1,589 | -3,397 |
| Depreciation Amortization | 65 | N/A | 35 | 163 | 224 |
| Accounts payable and accrued liabilities | -29 | 389 | 104 | 99 | 895 |
| Other Working Capital | 848 | 702 | 683 | 1,012 | 3,376 |
| Other Operating Activity | 1,071 | 1,864 | -4,639 | -3,055 | -1,099 |
| Operating Cash Flow | $-408 | $-582 | $-232 | $-192 | $-1 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | -500 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -500 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-500 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 188 | 315 | N/A | N/A | N/A |
| Debt Issued | 100 | 417 | N/A | 197 | N/A |
| Other Financing Activity | 0 | 6 | 716 | 0 | 0 |
| Financing Cash Flow | $287 | $738 | $716 | $197 | $N/A |
| Beginning Cash Position | 151 | 494 | 10 | 5 | 6 |
| End Cash Position | 30 | 151 | 494 | 10 | 5 |
| Net Cash Flow | $-121 | $-343 | $484 | $5 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -408 | -582 | -232 | -192 | -1 |
| Free Cash Flow | -408 | -582 | -232 | -192 | -1 |